| Company/Division name | Nexus Pharmaceuticals Inc. |
| Parent company | Nexus Pharmaceuticals Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2023 |
| Year reshoring implemented or to be implemented: | 2023 |
| City reshored to: | Pleasant Prairie |
| State(s) reshored to: | WI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | sterile pharmaceutical manufacturing |
| What non-domestic negative factors made offshoring less attractive? | Quality/rework/warranty, Regulatory compliance, Supply chain interruption |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies |
